First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta 2),in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

Pfeiffer, Norbert; Voykov, Bogomil; Renieri, Giulia; Bell, Katharina; Richter, Paul; Weigel, Melanie; Thieme, Hagen; Wilhelm, Barbara; Lorenz, Katrin; Feindor, Martin; Wosikowski, Katja; Janicot, Michel; Paeckert, Daniela; Roemmich, Regina; Mala, Carola; Fettes, Petra; Leo, Eugen

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta 2),in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

Autor(en):

Pfeiffer, Norbert; Voykov, Bogomil; Renieri, Giulia; Bell, Katharina; Richter, Paul; Weigel, Melanie; Thieme, Hagen; Wilhelm, Barbara; Lorenz, Katrin; Feindor, Martin; Wosikowski, Katja; Janicot, Michel; Paeckert, Daniela; Roemmich, Regina; Mala, Carola; Fettes, Petra; Leo, Eugen

Tübinger Autor(en):

Richter, Paul
Wilhelm, Barbara
Voykov, Bogomil Nikolov

Erschienen in:

Plos One (2017), Bd. 12, Article e0188899

Verlagsangabe:

Public Library Science

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1371/journal.pone.0188899

ISSN:

1932-6203